A review of the results of uterine artery embolisation for the treatment of adenomyosis

article OA: green CC0
⚙ AI-generated deep summary by claude@2026-06, 2026-06-17 · read from full text ⓘ

This ECR 2025 educational exhibit reviewed reported outcomes of uterine artery embolisation (UAE) in patients with symptomatic adenomyosis, focusing on changes in symptoms and quality of life across short- and long-term follow-up and on fertility outcomes. It reports substantial symptom improvement (83% short-term vs 65% long-term) and cites a systematic review (De Bruijn et al., 2017) where pregnancies were rare (6 of 99 patients) and where no utero-placental vascular insufficiency or abnormal uterine contractions were observed in the available labour/postpartum data; major complications are noted but not detailed in the provided text. A stated caveat is that fertility preservation has been reported yet permanent amenorrhea and potential impacts on ovarian perfusion are also described, with recommendation language emphasizing use in patients who have completed childbearing. This paper is centrally about adenomyosis — specifically, it reviews UAE effectiveness for symptomatic adenomyosis and associated fertility and complication considerations.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 3,600 characters · extracted from oa-html · 4 sections · click to expand

Keywords

Genital / Reproductive system female, Catheter arteriography, Embolisation, Embolism / Thrombosis, Outcomes Authors: L. Lyons, J. Clarke, A. G. Ryan DOI: 10.26044/ecr2025/C-25619 Learning objectives Uterine artery embolisation (UAE) is a defined treatment option for symptomatic uterine leiomyomas, however, its use to treat adenomyosis is not yet clearly defined in clinical practice. We wished to evaluate the impact of uterine artery embolisation on symptoms and quality of life (QoL) in patients with adenomyosis and to examine the impact of uterine artery embolisation on fertility.

Background

Adenomyosis is a benign condition characterised by ectopic endometrial glands and stroma in the myometrium [Figure. 1 and Figure. 2] which can occur in isolation or concomitantly with fibroids. Adenomyosis can cause significant abnormal uterine bleeding, dysmenorrhea and chronic pelvic pain severely affecting quality of life. Historical treatment options typically comprised conversative medical management options involving non-steroidal antiflammatory drugs, the oral contraceptive pill and intrauterine devices. If these failed to manage the person’s symptoms, either asking the patient to live with their symptoms or referring... Findings and procedure details Significant improvement in symptoms in both short and long term follow up has been described, ranging from 83% in the short term versus 65% in the long term follow up [Figure 5 and Figure 6]. A systematic review by De Bruijn et al (2017), found that 2 of 34 studies reported pregnancies following UAE, 6 patients out of 99 becoming pregnant. There were no signs of utero-placental vascular insufficiency or abnormal uterine contractions observed during labour or postpartum. Complications of UAE in these cohorts described...

Conclusion

Uterine artery embolisation is an effective treatment alternative for women with symptomatic adenomyosis who wish to avoid hysterectomy. Although preservation of fertility has been reported, permanent amenorrhea has also been reported, thus uterine artery embolisation is currently recommended to women who have completed their families. Patients with severe symptoms uncontrolled with conservative measures who are being offered hysterectomy can be offered UAE as an alternative. In all cases, the patient must be warned about the potential impact on ovarian perfusion with resultant diminished fertility and... Personal information and conflict of interest L. Lyons: Nothing to disclose J. Clarke: Nothing to disclose A. G. Ryan: Nothing to disclose

References

De Bruijn. A, Smink. M, Lohle. P, Huirne. J, Twisk. J, Wong. C, Schoonmade. L, and Hehenkamp. W (2017). Uterine Artery Embolization for the Treatment of Adenomyosis: A Systematic Review and Meta-Analysis. J Vasc Interv Radiology. 28(12), pp.1629-1642. [Online]. Available at: https://www-clinicalkey-com.proxy.library.rcsi.ie/service/content/pdf/watermarked/1-s2.0-S1051044317. E. Liang. (2021). Uterine ArteryEmbolisationfor Adenomyosis. [Online].https://www.sydneyfibroidclinic.com.au/adenomyosis/about-adenomyosis/. Last Updated: 2021. Available at:https://www.sydneyfibroidclinic.com.au/adenomyosis/about-adenomyosis/[Accessed 10 February 2025]. E. Liang R. Parvez, S. Ng and B. Brown. (2024). Uterine artery embolisation for adenomyosisin women who failed prior endometrial ablation. CVIR Endovascular. 7(59), pp.1-5. [Online]. Available at:...

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-10T10:49:32.617928+00:00
License: CC0 · commercial use OK